Phagenesis Limited

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Phagenesis Limited - overview

Established

2007

Location

Manchester, England, UK

Primary Industry

Medical Devices & Equipment

About

Founded in 2007 and based in Manchester, UK, Phagenesis Limited operates as a private healthcare company focused on developing treatments for dysphagia, specifically neurogenic dysphagia. In March 2024, the firm raised GBP 33. 1 million in Series D funding co-led by investors EQT Life Sciences and Sectoral Asset Management, with participation from other investors British Patient Capital, Northern Gritstone, and Aphelion Capital. The company offers Phagenyx® Neurostimulation System, this device is used for the treatment of dysphagia, a medical term for patients with difficulty in swallowing.


This system features a dual-function catheter capable of both delivering stimulation and feeding, tailored to individual patient needs. The therapy aims to restore neurological control over swallowing. The company plans to use the March 2024 funding to support its commercialization across the United States and Europe, clinical trials, regulatory activities, as well as research and development.


Current Investors

EQT Life Sciences, Aphelion Capital, Sectoral Asset Management

Primary Industry

Medical Devices & Equipment

Sub Industries

Therapeutic Devices

Website

www.phagenesis.com

Total Amount Raised

Subscriber access only

Phagenesis Limited - employee data

Blurred Background

Want to see Employee Count?

Request a demo for full access to this profile.

Phagenesis Limited - key contacts

NamePositionStart DateEnd DateVcardBio 
Chairman Of The BoardBM

BM Board Member

Want to see more?

Request a demo for full access to this profile

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.